China Dasheng Biotechnology Company (CDBT)

USD 0.05

(0.0%)

Annual Income Statements

(In USD)
Breakdown 2023 2022 2008 2006
Revenue - - 16.29 Million 484.83 Thousand
Cost of Revenue - - 8.79 Million 365.03 Thousand
Gross Profit - - 7.5 Million 119.8 Thousand
Operating Expenses 657.46 Thousand - 2.42 Million 136.67 Thousand
Selling, General and Administrative Expenses 560.93 Thousand - 2.42 Million 136.67 Thousand
Research and Development Expenses - - - -
Other Expenses - - - -
Cost and Expenses 657.46 Thousand - 11.21 Million 501.7 Thousand
Operating Income -657.46 Thousand - 5.07 Million -16.86 Thousand
Interest Expense 359.82 Thousand - 41.76 Thousand -
Income Tax Expense - - 436.63 Thousand -
Earnings before Tax -966.71 Thousand - - -
Net Income -966.71 Thousand - 4.63 Million -16.86 Thousand
Earnings Per Share Basic -0.02 - 0.15 -0.00
Earnings Per Share Diluted -0.02 - 0.15 -0.00
Weighted Average Shares Outstanding 40.97 Million 25.7 Million 30 Million 9.1 Million
Weighted Average Shares Outstanding (Diluted) 40.97 Million 25.7 Million 30 Million 9.1 Million
Gross Margin - - 0.46 0.25
EBIT Margin - - 0.35 -0.03
Profit Margin - - 0.28 -0.03
EBITDA -636.92 Thousand - 5.7 Million -15.24 Thousand
Earnings Before Tax Margin - - 0.31 -0.03

Income Statement Charts